Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.34 |
| ▸ | CYSLTR2 | Q9NS75 | 1/20 | 0.34 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.34 |
| ▸ | MGLL | Q99685 | 1/20 | 0.33 |
| ▸ | TOP2A | P11388 | 1/20 | 0.32 |
| ▸ | THRA | P10827 | 3/20 | 0.32 |
| ▸ | THRB | P10828 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | TRPV1 | Q8NER1 | 1/20 | 0.32 |
| ▸ | ZDHHC2 | Q9UIJ5 | 1/20 | 0.32 |
| ▸ | PPARG | P37231 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | TBXA2R | P21731 | 3/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15167151 | 1.00 | SMN1; SMN2 (0.34) | SMN1; SMN2KMT2ACYSLTR2CYSLTR1MGLL | |
| SCHEMBL54670 | 0.83 | THRA (0.34) | SMN1; SMN2KMT2AMGLLTOP2ATHRA | |
| SCHEMBL54671 | 0.83 | THRA (0.34) | SMN1; SMN2KMT2AMGLLTOP2ATHRA | |
| SCHEMBL28187749 | 0.83 | TXNRD1 (0.33) | SMN1; SMN2KMT2AMGLLTHRATHRB | |
| SCHEMBL9842860 | 0.78 | THRA (0.44) | KMT2ACYSLTR2CYSLTR1THRATHRB | |
| SCHEMBL9842852 | 0.78 | THRA (0.44) | KMT2ACYSLTR2CYSLTR1THRATHRB | |
| SCHEMBL12993996 | 0.78 | L3MBTL1 (0.39) | KMT2AL3MBTL1 | |
| SCHEMBL676763 | 0.75 | TDP1 (0.53) | KMT2ACYSLTR2CYSLTR1MGLL | |
| SCHEMBL20451 | 0.75 | TDP1 (0.53) | KMT2ACYSLTR2CYSLTR1MGLL | |
| SCHEMBL12676246 | 0.75 | TDP1 (0.41) | SMN1; SMN2KMT2AL3MBTL1TBXA2R |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 362 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9420780-B2 | Composition, method for producing the composition, and phytosanitary formulation containing same | RHODIA OPERATIONS (FR) | 2016-08-23 | — | — | US | disclosed |
| US-20160000066-A1 | Furfural derivatives as a vehicle | INSTITUT NATIONAL DE LA RECHERCHE AGRONOMIQUE (INRA) (FR) | 2016-01-07 | — | — | US | disclosed |
| US-9090538-B2 | Uses of esteramide compounds | RHODIA OPERATIONS (FR) | 2015-07-28 | — | — | US | disclosed |
| US-8981148-B2 | Esteramide compounds, methods for preparing same, and uses thereof | RHODIA OPERATIONS (FR) | 2015-03-17 | — | — | US | disclosed |
| US-8877681-B2 | Use of specific alcohol alkoxylates as an adjuvant for agrotechnical applications | BASF SE (DE) | 2014-11-04 | — | — | US | disclosed |
| US-8802120-B2 | Bioactive agrichemical compositions and use thereof | SCIESSENT LLC (US) | 2014-08-12 | — | — | US | disclosed |
| EP-1659864-B1 | METHOD OF PLANT GROWTH PROMOTION USING AMIDE COMPOUNDS | BASF SE (DE) | 2013-09-18 | — | — | EP | disclosed |
| US-20130210933-A1 | NOVEL USES OF ESTERAMIDE COMPOUNDS | RHODIA OPERATIONS (FR) | 2013-08-15 | — | — | US | disclosed |
| US-20130210634-A1 | NOVEL ESTERAMIDE COMPOUNDS, METHODS FOR PREPARING SAME, AND USES THEREOF | RHODIA OPERATIONS (FR) | 2013-08-15 | — | — | US | disclosed |
| US-20130012556-A1 | Bioactive Agrichemical Compositions and Use Thereof | SCIESSENT LLC (US) | 2013-01-10 | — | — | US | disclosed |
| US-4271308-A | FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1981-06-02 | — | — | US | disclosed |
| US-4241079-A | ANTHELMINTICS AND FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1980-12-23 | — | — | US | disclosed |
| US-4235928-A | Substituted cyanamides and their use as fungicides | BASF AKTIENGESELLSCHAFT (DE) | 1980-11-25 | — | — | US | disclosed |
| US-4225723-A | Process for the preparation of substituted arylcyanoalkyl and diaryl cyanoalkylimidazoles | ROHM AND HAAS COMPANY (US) | 1980-09-30 | — | — | US | disclosed |
| US-4199503-A | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1980-04-22 | — | — | US | disclosed |
| US-4198423-A | FUNGICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1980-04-15 | — | — | US | disclosed |
| US-4143137-A | SUBSTITUTED ARYLCYANOALKYL AND DIARYLCYANOALKYLIMIDAZOLE METAL SALT COMPLEXES AND FUNGICIDAL COMPOSITIONS AND METHODS UTILIZING THEM | ROHM AND HAAS COMPANY (US) | 1979-03-06 | — | — | US | disclosed |
| US-4120864-A | FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1978-10-17 | — | — | US | disclosed |
| US-4079146-A | FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1978-03-14 | — | — | US | disclosed |
| US-4073921-A | FUNGICIDES | ROHM AND HAAS COMPANY (US) | 1978-02-14 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130210933-A1 | NOVEL USES OF ESTERAMIDE COMPOUNDS | CECR2, CES2, ERLIN2 | SMN1; SMN2 4363/4885KMT2A 1200/4885CYSLTR2 360/4885 |
| US-20160000066-A1 | Furfural derivatives as a vehicle | C1R, FRG1, FAR1 | SMN1; SMN2 3733/4885KMT2A 4210/4885CYSLTR2 1960/4885 |
| US-20130210634-A1 | NOVEL ESTERAMIDE COMPOUNDS, METHODS FOR PREPARING SAME, AND USES THEREOF | CNR2, CRHR2, HRH3 | SMN1; SMN2 3629/4885KMT2A 969/4885CYSLTR2 138/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.